Browsing Tag

Pfizer-BioNTech

Pfizer-BioNTech begin clinical trials of Covid-19 vaccine specific to Omicron variant

Jan 26, 2022

German biotechnology company BioNTech and US company Pfizer have started clinical trials of an Omicron-based Covid-19 vaccine candidate in healthy adults from 18 through 55 years of age, the companies have said. The trials would evaluate…
Read More...

UK approves Pfizer-BioNTech Covid-19 vaccine children aged 5 to 11

Dec 22, 2021

Britain's medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer and BioNTech for children aged 5 to 11 years, after the watchdog found the shot was safe and effective. The country's vaccines committee…
Read More...